3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
Compound with spectra: 1 NMR
![3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE](/api/compound/GiZfoEiBWO8.png?ph=true&h=300&w=458 "3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE")
| SpectraBase Compound ID | GiZfoEiBWO8 |
|---|---|
| InChI | InChI=1S/C24H20FN5O2/c1-2-30-19-6-4-3-5-17(19)18-13-16(8-9-20(18)30)27-22(31)11-12-23-28-24(29-32-23)15-7-10-21(25)26-14-15/h3-10,13-14H,2,11-12H2,1H3,(H,27,31) |
| InChIKey | QVJCGAGCPWFQGZ-UHFFFAOYSA-N |
| Mol Weight | 429.46 g/mol |
| Molecular Formula | C24H20FN5O2 |
| Exact Mass | 429.160103 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3:CD3OD=1:1 |
2-[(5-ethoxy-1H-benzimidazol-2-yl)sulfanyl]-N-(9-ethyl-9H-carbazol-3-yl)acetamide
N-(9-ethyl-3-carbazolyl)-2-[(6-nitro-1H-benzimidazol-2-yl)thio]acetamide
3-[3-(2-BROMO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-METHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
3-((4-Chlorophenyl)amino)-2-cyano-N-(9-ethyl-9H-carbazol-3-yl)-3-(methylthio)acrylamide
benzamide, N-(9-ethyl-9H-carbazol-3-yl)-2,4-dimethoxy-
3-(Allylamino)-5-amino-N-(9-ethyl-9H-carbazol-3-yl)-1H-pyrazole-4-carboxamide
(2E)-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-propenenitrile
(2E)-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-(4-phenyl-1,3-thiazol-2-yl)-2-propenenitrile
benzenesulfonamide, N-(9-ethyl-9H-carbazol-3-yl)-2-nitro-
9H-Carbazole, 3,3'-azoxybis[9-ethyl-
| Title | Journal or Book | Year |
|---|---|---|
| Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation | Organic and Medicinal Chemistry Letters | 2012 |